Skip to content

Tailored Case Management for Diabetes and Hypertension

Tailored Case Management for Diabetes and Hypertension

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00978835
Acronym
TEACH-DM
Enrollment
377
Registered
2009-09-17
Start date
2008-05-31
Completion date
2013-07-31
Last updated
2014-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Hypertension

Keywords

Diabetes, Hypertension, Physical Activity, Diet, Medication Adherence

Brief summary

Diabetes and hypertension co-exist in approximately 10 million people in the USA and constitute severe risk factors for the development of such complications as heart and kidney disease. The investigators propose a randomized controlled trial in patients of community primary care practices to study a tailored telephone-administered behavioral intervention to improve control of blood pressure and blood sugar in patients with both hypertension and diabetes. The investigators hypothesize that 20% more patients talking to a nurse every other month about ways to improve blood pressure and blood sugar control will bring their blood pressure under control when compared to patients who talk with the nurse only about general health issues. If successful in improving control of these diseases this intervention can easily be adopted in other community primary care practices to lessen the burden of diabetes and hypertension in the USA.

Interventions

BEHAVIORALTailored telephone-based case management

Telephone calls by a nurse every two months to assess adherence to diet, physical activity, and pill-taking regimens. The nurse will then identify barriers to adherence to these recommendations and use motivational interviewing approaches to offer solutions to the barriers identified. No changes to medication are made.

BEHAVIORALNurse Education

Didactic, non-interactive education by a nurse on general health topics. Calls are made every two months.

Sponsors

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH
Duke University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Enrolled and receiving primary care at one of 9 participating clinics in North Carolina * Diagnosis of diabetes as determined by billing data * Taking medication for diabetes * Diagnosis of hypertension as determined by billing data * Taking medication for hypertension * Most recent (within one year) Hemoglobin A1c \>= 7.5%

Exclusion criteria

* Active psychosis * Hospitalization for stroke, myocardial infarction (MI), or coronary artery revascularization in the past 6 months * Type I diabetes * Does not speak English * No access to a telephone * Institution-dwelling or receiving comprehensive professional home health care * Hearing or speech inadequate for long interactive phone conversations * Terminal illness or active treatment for cancer * Cognitive impairment too severe to understand instructions

Design outcomes

Primary

MeasureTime frame
Blood Pressure2 years

Secondary

MeasureTime frame
Hemoglobin A1c2 years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026